INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2019

Higher admission plasma TMAO levels were linked to increased risks of poor functional outcome and mortality at 3 months in acute ischemic stroke patients.

Researchers prospectively recruited 225 acute ischemic stroke patients to examine the link between admission plasma TMAO levels and 3-month outcomes. At 3 months, 116 patients (51.6%) had a poor functional outcome and 51 patients (22.7%) had died. After adjusting for potential confounders, patients in the highest TMAO quartile had higher risks of poor functional outcome (OR 3.63; 95% CI 1.34-9.82; P = 0.011) and mortality (OR 4.27; 95% CI 1.07-17.07; P = 0.040) compared with the lowest quartile.

Shows an association, not proof of cause and effect.

Study type
Prospective cohort study
Who was studied
225 acute ischemic stroke patients diagnosed within 24 hours of symptom onset
What was measured
Poor functional outcome (mRS 3-6) and mortality at 3 months

THE PAPER

Prognostic Value of Plasma Trimethylamine N-Oxide Levels in Patients with Acute Ischemic Stroke.

Zhai Q, Wang X, Chen C, Tang Y, Wang Y, Tian J, Zhao Y, Liu X. Cell Mol Neurobiol, 2019.

PubMed 31332666 ↗DOI 10.1016/j.cell.2016.02.011 ↗

Gut & microbiomeBrain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.